ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Glomerular filtration rate (GFR)"

  • 2015 American Transplant Congress

    Estimation of Glomerular Filtration Rate With Serum Cystatin C Accurately Discriminates Renal Dysfunction in Liver Transplant Candidates With End-Stage Liver Disease

    S. Gonzalez,1 J. Trotter,1 H. Szerlip,2 M. Levy,3 A. Chandrakantan,4 A. Yango,4 A. Rajagopal,4 Y. Barri,4 K. Rice,4 M. Saim,2 L. Melton,4 M. Emmett,2 G. Klintmalm,3 B. Fischbach.4

    1Hepatology, Baylor Simmons Transplant Institute, Fort Worth, TX; 2Nephrology, Baylor University Medical Center, Dallas, TX; 3Transplant Surgery, Baylor Simmons Transplant Institute, Fort Worth, TX; 4Nephrology, Baylor Simmons Transplant Institute, Fort Worth, TX.

    Background: Renal insufficiency is common in end-stage liver disease (ESLD) and is linked to survival in patients awaiting liver transplantation. Serum creatinine correlates poorly with…
  • 2015 American Transplant Congress

    Living Donor Characteristics Associated With Changes in Post-Donation GFR

    E. Poggio,1 D. Mandelbrot,4 P. Reese,5 D. Goldfarb,3 S. Flechner,3 J. Schold.2

    1Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH; 2Qualitative Health Sciences, Cleveland Clinic, Cleveland, OH; 3Urology, Cleveland Clinic, Cleveland, OH; 4Division of Medicine, University of Wisconsin, Madison, WI; 5Nephrology, University of Pennsylvania, Philadelphia, PA.

    Living donor transplantation is the preferred modality for treatment of ESRD because it confers excellent outcomes for recipients and poses reasonable risks to most donors.…
  • 2015 American Transplant Congress

    1-Year Safety and Efficacy of Eculizumab in Adult aHUS Patients, With or Without a History of Renal Transplant

    C. Legendre,1 J. Kincaid,2 C. Bedrosian,2 C. Loirat.3

    1University Paris Descartes & Hôpital Necker, Paris, France; 2Alexion, Cheshire, CT; 3Assistance Publique–Hôpitaux Paris, Hôpital Robert-Debré, Paris, France.

    Background: Atypical hemolytic-uremic syndrome (aHUS) is a life-threatening, chronic disease of complement-mediated TMA. In aHUS, renal transplantation is associated with post-transplant (TP) TMA and ∼50–70%…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences